3D Systems (NYSE: DDD) reported Q2 2026 results on August 4, 2026, with revenue of $94.6M (down 0.3% YoY, but up 1.4% excluding the software divestiture), slightly above the analyst consensus of $93.76M. Non-GAAP EPS came in at -$0.04, beating expectations of -$0.05, and Adjusted EBITDA was -$0.8M, an improvement of 81.8% YoY. The company held $129M in cash as of June 30. Shares rose ~9% in after-hours trading. Metal additive manufacturing was the standout growth driver this quarter. CEO Jeffrey Graves highlighted double-digit growth in both metal and polymer hardware printer systems, with metal 3D printing expanding its footprint across four core markets: medical technology, aerospace & defense, and data center infrastructure. Segment breakdown: Healthcare solutions generated $48.1M (+6.8% YoY, 50.8% of revenue), with med tech growing over 20%. Industrial solutions brought in $46.5M (-6.7% YoY), but aerospace & defense and data center infrastructure each grew over 20%. 3D Systems is in a strategic transition from polymer-centric to a balanced metal AM portfolio, and the acceleration in metal hardware shipments in Q2 validates this strategy. Q3 guidance calls for revenue of $96-99M and Adjusted EBITDA between -$3M and $1M, reflecting management's confidence in continued improvement in the second half. The company is also advancing a $28M government-funded metal printer R&D project. Value for powder buyers: 1) Double-digit metal hardware printer growth directly boosts demand for medical- and aerospace-grade powders such as titanium alloys (Ti64), nickel-based superalloys (IN718/IN625), and cobalt-chrome (CoCrMo) — a growing installed base of 3D Systems equipment means sustained increases in powder consumption. 2) The 20% growth in med tech is especially positive for dental and orthopedic implant powders (CoCrMo/Ti64 ELI); the 20% aerospace growth benefits superalloy powders. 3) Watch for tender activity from 3D Systems' powder suppliers for its equipment, as well as potential new powder specifications arising from the $28M government R&D program.